Champalimaud Research scientists uncovered potential new therapeutic avenues for reducing stores of visceral fat, which are associated with obesity, obesity-related cardiovascular disease, and cancer. The mouse studies identified the first known neuro-immune process by which brain signals instruct immune function in visceral fat stores, and could help point to new ways of fighting visceral obesity and reducing the risks of cardiovascular disease and cancer.